As we come to the end of 2022 and our first year as a listed company, the year in review shows a clear theme of growth and expansion across…

Biomarker Discovery A biomarker is a measurable indicator showing the presence or severity of a disease state. Using biomarkers to differentiate between healthy and diseased cells can enable…

04/02/2020 Biotechnology companies Aptamer Group and Valitacell Ltd have joined forces to develop a next-generation screening platform for drug development. Aptamer Group will be working alongside Valitacell…